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Abstract
Background: Suboptimal prescribing and medications use is a problem for health systems globally. Systematic
reviews are a comprehensive resource that can help guide evidence-informed decision-making and implementation of
interventions addressing such issues; however, a barrier to the use of systematic reviews is their inaccessibility (due to
both dispersion across journals and inaccessibility of content). Publicly available databases, such as Rx for Change,
provide quick access to summaries of appraised systematic reviews of professional and consumer-oriented
interventions to improve prescribing behaviour and appropriate medication use, and may help maximise the use of
evidence to inform decisions. The present study aims to evaluate a training program to improve attitudes towards,
confidence in skills, intentions to use, and use of systematic review evidence contained within Rx for Change.
Methods: Guided by the Knowledge to Action framework, a training program with content customised to local
provider and consumer contexts was developed with knowledge user input. The training program consisted of a
6 minute information video, a 1 hour workshop with hands-on, interactive and didactic components, and two
post-training reminders. Forty-nine people from five medicines-focused organisations in Canada and Australia
attended one of six workshops. Participants were surveyed immediately pre and post and 3 months after training to
evaluate their attitudes towards, confidence in skills, intentions to use, and use of Rx for Change, and attitudes towards
and confidence in skills for using evidence for decision-making. Analyses for differences for each of the outcomes at
three time points (pre, post and 3 months after training) was performed using a random effects model.
Results: Immediately post-training, there were higher respondent attitudes towards Rx for Change (mean increase = 0.
54 out of 5, 95% CI, 0.18–0.83, P < 0.005); intention to use Rx for Change (0.53, 95% CI, 0.21–0.86, P < 0.005); confidence
in skills for using Rx for Change (2.08, 95% CI, 1.74–2.42, P < 0.005); and confidence in skills for using evidence in policy
decision-making (0.50, 95% CI, 0.22–0.77, P < .005) compared to pre-training. Confidence in skills for using both Rx for
Change and evidence were maintained 3 months after training (both P < 0.005).
Conclusions: Participants of this training program reported sustained improvements in their confidence in skills for
using evidence in policy decision-making. This may have important implications for uptake of systematic review
evidence promoting improved prescribing and medication use.
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Background
Health systems globally are focused on addressing in-
appropriate prescribing by healthcare professionals (pro-
viders) and inappropriate use of medications by patients
(consumers) to maximise patient outcomes and minim-
ise healthcare costs [1, 2]. Sub-optimal medication use
and prescribing practices exist across most high-income
countries [1, 3], with medication errors, mistakes and la-
boratory error in Australia and Canada being reported
for approximately 27% and 30% of patients, respectively
[1]. Poor prescribing practices and medication errors are
associated with negative health outcomes, including in-
creased morbidity [4] and preventable hospital admissions
[5], increased rates of antibiotic resistant organisms due to
overprescribing of antibiotics [6] and high rates of prevent-
able adverse drug events [7]. Suboptimal medication use
by patients is also problematic, with adherence to medi-
cines rates of approximately 50% [2]. Problems affecting
consumers’ use of medicines include high rates of errors
by prescribers and patients, preventable adverse effects,
and difficulties in communication and transitional care [8].
Systematic reviews comprehensively synthesise avail-
able evidence about potential policies and interventions
to improve medication use but knowledge users find it
difficult to access relevant systematic reviews and make
sense of research evidence [9]. Knowledge users also face
significant challenges to using systematic review evi-
dence. Some of the most frequently identified barriers
by knowledge users include constraints on time and re-
sources, and resistance towards change [10]. Knowledge
users report that increasing the use of research evidence
for policy decision-making requires more accessible and
efficient systems as well as approaches to ensuring ac-
countability for evidence use [10]. There are also barriers
related to the context in which policy decision-making
occurs, including varying pressure from multiple interest
groups, limited time for decision-making and the use of
research evidence being one of many types of informa-
tion required for policy decision-making [9]. Further
barriers to evidence-informed decision-making include
lack of senior-level leadership and support for using
evidence, politicised (as opposed to evidence)
decision-making and constant shifting of attention
across changing priorities making a focus on evidence
impossible [11].
In response to these challenges, a range of innovative
knowledge translation resources have been developed to
facilitate the use of evidence to inform decision-making,
including simplified frameworks developed with contri-
bution from the policy sector to better understand how
any given approach to increasing the use of evidence can
be applied and understood [12], websites to facilitate re-
search engagement by policymakers [13], and databases
to facilitate access to evidence [14, 15]. The Cochrane
Collaboration has developed training courses for system-
atic review use specific to public health [16] and over-
views of systematic reviews have been published to
facilitate summaries of evidence [8, 17].
One such freely available online database is Rx for
Change, an evidence-based resource of appraised and
summarised evidence on the effectiveness of interven-
tions targeting healthcare professionals and patients to
improve prescribing and medication use [14] (http://
www.rxforchange.ca). Rx for Change is a collaboration
between researchers at the Cochrane Effective Practice
and Organisation of Care (EPOC) Group and the
Cochrane Consumers and Communication Review
Group (CC&CRG) primarily funded by the Canadian
Agency for Drugs and Technologies in Health [14].
Between 2007 and April 2014, the database was period-
ically updated to ensure that this evidence remains rele-
vant and timely. To populate the database, potentially
relevant systematic reviews of interventions targeting
professionals (e.g. audit and feedback) and consumers
(e.g. acquiring skills and competencies) were identified
by sensitive searches of major databases including Med-
line, The Cochrane Library, and EMBASE. Full text copies
of potentially relevant reviews were retrieved and assessed
for relevance [8]. Each review was quality-assessed using
AMSTAR, an instrument validated for assessing quality of
systematic reviews [18–20]. High and medium quality
reviews (AMSTAR score > 4) were data-extracted and
summarised using a structured process to highlight
key characteristics and evidence relevant to optimal
use of medicines decision-making. To facilitate the
ease of finding and using information, the Rx for
Change database is organised according to interven-
tion type (e.g. education, reminders, etc.) and category
(e.g. professional, consumer, organisational, financial,
regulatory) using taxonomies developed by EPOC and
CC&CRG [21]. Currently, Rx for Change contains
more than 300 summarised reviews that synthesise
findings from thousands of individual studies, span-
ning all conditions and diseases, and evaluating inter-
ventions targeting healthcare provider or consumer
behaviours to improve medication prescribing or use.
The primary objective of Rx for Change is to maximise
the awareness and use of appraised systematic reviews of
professional and consumer-oriented interventions to im-
prove prescribing behaviour and appropriate medication
use. There has been a steady trend of increased site visits
and time spent on the site since its inception and the
database has received positive feedback from healthcare
providers, researchers and policymakers [14]. However,
despite efforts to increase the use of Rx for Change (e.g.
an on-line tutorial), anecdotal evidence suggests the
need for further training to maximise use of the database
for evidence-informed decisions.
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Objectives
The aim of this project was to develop and evaluate a
training program for Rx for Change in collaboration with
relevant knowledge users. The development of the train-
ing was guided by the Knowledge to Action framework
[22]. This framework outlines the necessary steps to
bridge the gap between knowledge and the application
of that knowledge in healthcare settings. The framework
steps emphasise collaboration with knowledge users and
includes adapting knowledge to the local context, under-
standing local barriers and tailoring interventions as
needed. The comprehensive findings of the development
stage of the training intervention (Phase 1), which in-
volved interviewing 16 knowledge users from a variety
of settings to identify the needs of the organisations and
to guide the content, delivery and tailoring of the work-
shop, are presented elsewhere [23]. The focus of the
current study (Phase 2) was to evaluate the resultant
training program in terms of its impact on subsequent
attitudes towards, confidence in skills, intentions to use,
and use of Rx for Change, as well as attitudes towards
and confidence in skills for using evidence in general.
Methods
This study used a pre–post design with a 3-month
follow-up. Five knowledge user organisations responsible
for the development of programs to improve prescribing
and medication use contributed to this project, three
from Canada (provider focused) and two from Australia
(consumer focused). All five of these organisations
expressed an interest in improving their use of Rx for
Change and a need for additional training. The three
Canadian sites focused on evidence for organisational,
professional and regulatory interventions, which are
consistent with the primary interest (and expertise) of
EPOC. Consistent with the primary interests (and ex-
pertise) of CC&CRG, the knowledge user organisations
from the two Australian sites focus primarily on evi-
dence for consumer-oriented interventions. The organi-
sations were a mix of national (n = 2), provincial (n = 3),
and government (n = 4) or non-government (n = 1) sites.
All programs provided support and information that was
needs driven, with the Canadian sites focusing on the
ultimate goal to influence local provider behaviour, and
the Australian sites focusing on consumer behaviour.
Stage 1
Training development
Key informants (n = 16) from each knowledge user organ-
isation participated in interviews to shape the content and
format for the training programs so that they were (1) tai-
lored to their needs and (2) designed to address provider
or consumer issues and barriers across the two countries.
The semi-structured interviews included questions on
their current use of evidence for decision-making, barriers
and facilitators to using evidence as well as the Rx for
Change database, and their needs and preferences for
training. The interviews were transcribed and analysed
using a directed content analysis [24]. The main themes
from the interviews identified the need for the workshops
to cover specific knowledge (e.g. definition of a systematic
review), skills for both navigating the database as well as
how to incorporate evidence into decision-making, activ-
ities to promote the routine use of Rx for Change, and the
need to address a variety of preferences for how the train-
ing should be delivered (tailoring). There was also an
interest in including practical and locally important exam-
ples on incorporating evidence within their workplace
context. In order to respond to this need and the desire to
learn how to use evidence for policy decision-making, we
developed a workshop that incorporated content from an
existing framework for using evidence in policy decision-
making – the SUPPORT Tool process [25]. The
SUPPORT Tool process includes the following steps:
identifying the problem and/or question at hand, What do
I want to achieve?; identifying the available options to ad-
dress the problem; identifying the available resources;
decision-making; and implementation of most suitable op-
tions. The developed training program consisted of (1) a
6 minute information video to be viewed prior to the
workshop (the video provided basic background informa-
tion about the database and systematic reviews); 2) a
60 minute face-to-face workshop with didactic, hands-on
and interactive components (these components included a
30 minute skills demonstration and practice with the data-
base that took participants through the SUPPORT Tool
process using a local and current prescribing-based issue
in the organisation); and (3) post workshop reminders at 1
and 3 months following the workshop to remind partic-
ipants about Rx for Change and encourage its use.
Following the development of the training, a final feasi-
bility check for the proposed training was completed
with a manager from each of the five participating orga-
nisations. A more comprehensive presentation of the
findings of the interviews and details of intervention
design that resulted from this initial stage of the project
is presented elsewhere [23].
Stage 2
Training program implementation and evaluation
Participants were recruited from each of the knowledge
user organisations via email invitations distributed to
one key contact within each of the organisations and for-
warded to potentially interested staff. The training was
delivered to the five knowledge user organisations (train-
ing was provided twice to one organisation with a sig-
nificant geographic range). Participants were surveyed
immediately pre and post and 3 months after training.
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The surveys included questions on self-reported use of
Rx for Change in the 3 months prior to the workshop
and in the 3 months following the workshop (i.e. how
many times in the past three months had they used Rx
for Change), attitudes towards using evidence and Rx for
Change for policy decision-making (i.e. their rating on a
scale from 1–5 as to the appropriateness, importance
and usefulness of both evidence and Rx for Change),
confidence in skills (i.e. rating on a scale of 1–5 for level
of confidence in six relevant skills for using evidence
and 11 relevant skills for using Rx for Change), and
intention to use Rx for Change (i.e. global rating of
intention on a scale from 1–5). Surveys were developed
for the study and were piloted in terms of relevancy,
clarity and completeness.
Given the large number of variables in the survey (i.e.
24), the problems associated with multiple testing [26],
and the fact that our survey contained many similarly
phrased questions for attitudes and skills, we planned a
principal component analysis of groupings of questions
in order to determine if the data supported the use of a
mean score for each of these groupings. The resulting
principal component analysis indicated that the group-
ings of questions were highly correlated – all corrected
item-total correlations were above the recommended
threshold of r > 0.30 [27]. We therefore, used these
groupings, and the associated mean scores, for the ana-
lysis under the four labels of (1) attitudes towards Rx for
Change, (2) confidence in skills for using Rx for Change,
(3) attitudes towards using evidence in decision-making,
and (4) confidence in skills for using evidence for
decision-making. Table 1 provides a detailed summary of
this analysis. Combined with intention (analysed as a
single variable), this gave us five outcomes to test.
Data analyses
The survey responses were analysed descriptively and
with frequencies and counts. Differences before and after
training as well as between provider and consumer ori-
ented organisations were analysed using a random ef-
fects model, with organisational unit used as a random
effect and robust variance estimates used for each of the
five outcome measures, each assessed on a scale from 1
to 5 time period (pre, post and 3 month follow-up) was
the exposure variable, with the pre-training time point
being used as the reference point. As participant re-
sponses were anonymised at the point of collection, re-
peated measures analyses could not be performed. To
formally test if the effect of the intervention may vary
between countries or organisations, interaction terms
were fitted between time points and these clusters. A
Bonferroni correction for multiple analyses (10
Table 1 Results of the principal component analysis
Grouping label Questions (5-point Likert scale) Principal component
analysis (r value)
Attitudes about evidence for decision-
making
Answer the following:
1. I think that using evidence in my decision-making is appropriate
2. I think that using evidence in my decision-making is important
3. I think that using evidence in my decision-making is useful
All > 0.88
Confidence in skills at using evidence for
decision-making
Rate level of confidence in the following skills:
1. Formulate an answerable question about an issue or topic related to my
work, to guide an online evidence search
2. Conduct an online evidence search to address the question
3. Critically appraise the research evidence
4. Determine how the evidence should be applied and transferred to my own
context
5. Overcome barriers in using evidence in my workplace
6. Overall confidence in using evidence in decision-making
All > 0.66
Attitudes about Rx for Change for
decision-making
Answer the following:
1. I think that using Rx for Change in my decision-making is appropriate
2. I think that using Rx for Change in my decision-making is important
3. I think that using Rx for Change in my decision-making is useful
All > 0.97
Confidence in skills at using Rx for
Change for decision-making
Rate level of confidence in the following skills:
1. Finding the Rx for Change database online
2. Navigating within the database
3. Knowing how best to use the “search” function
4. Finding the intervention level summaries
5. Understanding the intervention level summaries
6. Finding the review level summaries
7. Understanding the review level summaries
8. Knowing where to find reviews
9. Knowing where to find the individual studies in the reviews
10. Understanding the review quality score
11. Interpreting the Rx for Change evidence so that I can apply it in my own
context
All > 0.62
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comparisons, two each for five outcome variables) was
used, resulting in a P value of < 0.005 being considered
as significant. All statistical analyses were undertaken
using Stata (v13.1, College Station, Tx).
Results
A total of 49 participants attended the workshops and
submitted the pre-workshop survey (one with incomplete
responses). For the post-training survey and 3-month
follow-up, we had 47 and 28 participants submit the survey,
respectively (two and one with incomplete responses,
respectively). Figure 1 provides a detailed summary of coun-
tries, organisations and surveys completed for all time
points. The participant sample was comprised of 79%
females (38 female, 10 male) and 88% full-time workers (42
full-time, 6 part-time). Of the participants attending the
workshops, 60% (29/48) had previously heard about the Rx
for Change database.
Self-reported use of Rx for Change
Prior to the training, 78% (38/49) of participants indi-
cated that they never used Rx for Change in the preced-
ing 3 months. When asked to consider their use of Rx
for Change in the 3 months since the training, only 39%
(11/28) indicated that they never used Rx for Change.
The number of people indicating that they used Rx for
Change in the previous 3 months at least 2–3 times per
month increased from 8% (4/49) during the 3 months
prior to the training to 32% (9/28) during the 3 months
after the training. Table 2 shows the full summary of
self-reported use of Rx for Change.
Statistical analysis for group differences
Differences in pre to post and pre to 3 month follow-up
Results indicated that confidence in skills to use Rx
for Change and confidence in skills to use evidence
were statistically significantly greater than pre training
at both the post and 3 month follow-up time points
(all P < 0.005). Attitudes towards using evidence for
decision-making were not significantly different from
pre training at post training (P = 0.635) or at 3 months
follow-up (P = 0.662). Both attitudes towards, and in-
tentions to use, Rx for Change increased at post training
(both P < 0.005), but not at follow-up (P = 0.445 and
P = 0.908, respectively). Table 3 provides a summary of the
analysis for group differences. There was no evidence that
either the organisational unit or country modified these
associations (all P values for interactions > 0.01), although
there was limited power to detect such effects.
Discussion
We developed user-informed training to increase the use
of an online database of systematic reviews (Rx for
Change) that policymakers could use to inform the de-
sign of programs to improve medication use. We tested
this training for effects on attitudes towards, confidence
in skills, intentions to use, and use of Rx for Change as
well as attitudes towards and confidence in skills for
using evidence for decision-making. We measured our
outcomes pre and post the training workshop as well as
at 3 months post training. Pre–post training effects were
found for attitudes towards, and confidence in skills for
using Rx for Change, as well as confidence in skills for
using evidence for decision-making. More importantly,
effects on confidence in skills for using Rx for Change
and for using evidence for decision-making were main-
tained at 3 months post training. Therefore, the results
indicate that this workshop, developed with input from
knowledge users and using an evidence-based process of
using evidence for policy decision-making as a guide,
has potential to improve immediate and long-term con-
fidence in skills in using this particular database, and in
using research evidence in general.
We combined several evidence-based approaches in
the design of our training. We used a workshop that in-
corporated interactive components [28], content tailored
to the needs and preferences of the knowledge users
[29], reminders [30], and the integration of knowledge
user input [22]. Systematic review evidence indicates
that each of these approaches has been shown to have
an effect on behaviour, albeit modest. Our training ap-
pears to have resulted in increased confidence in skills
and increased use of Rx for Change, although it did not
have an effect on intention, thus reducing the likelihood
of sustaining the increased use of Rx for Change [31].
The use of a 1-hour workshop is a common approach to
education and behaviour change [32] and the leads in
our knowledge user organisations had a preference for
this style of training as it fits with demands placed on
staff in these organisations. While more understanding
is needed as to dosage and the types of educational
activities for maximising effects, it continues to be
worthwhile to test the effects of short educational
training interventions and ensure follow-up measures
Fig. 1 Number of participant responses for pre, post and follow-up
surveys at each site
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to optimise our understanding of the maintenance of
any gains made.
There were no significant differences observed in atti-
tudes towards using evidence for decision-making at any
time point. Given the high pre-training means for this
variable (4.74 on a 5 point scale), there was either little
room for improvement (suggesting a ceiling effect) or
our scale was not able to detect differences. Attitudes to-
wards using evidence tend to be positive, even if behav-
iour is not consistent with this attitude. Programs of this
nature should probably not solely focus their efforts on
changing attitudes towards using evidence but rather be-
haviours around the use of evidence. We did not observe
any differences in intentions to use Rx for Change at the
3 month follow-up. The reasons for this are unclear, but
could include perceptions of the value and/or function-
ality of the database itself or broader issues related to
the use of evidence in general. Although we did incorp-
orate the needs and preferences of the knowledge users
into the training, we focused on this local input, perhaps
at the expense of considering other barriers to change
such as organisational culture [33]. While a 1 hour
workshop can only cover a limited amount of content,
future efforts to address knowledge user needs as well as
other barriers identified in the literature is warranted.
Forty percent of the sample indicated that they had
not used Rx for Change since the training, yet there were
fewer participants who indicated that they did not use
Rx for Change in the 3 months after training than in the
3 months prior to training. We were unable to explore if
participants had a need to use Rx for Change since the
training, making it difficult to fully interpret our Rx for
Change use data. However, the results suggest that with
no change in their intentions to use Rx for Change, a de-
crease in their attitudes towards it, and confidence in
skills potentially declining, it is likely that use rates will
revert to pre-training levels. This is often the case in
knowledge translation interventions [34], and methods
for promoting knowledge translation intervention sus-
tainability are needed.
Table 3 Statistical Analysis for Group Differences
Pre – time point mean
(95% CI)
Post – time point mean difference
from pre (95% CI)
P value
3 month – time point mean difference
from pre (95% CI)
P value
n n n
Attitudes towards using evidence for
decision-makinga
4.75 (4.59 to 4.91)
n = 49
−0.05 (−0.27 to 0.17)
P = 0.635
n = 46
0.06 (−0.21 to 0.33)
P = 0.662
n = 28
Confidence in skills for using evidenceb 3.60 (3.40 to 3.81)
n = 49
0.50 (0.22 to 0.77)
P < 0.005
n = 45
0.53 (0.23 to 0.82)
P < 0.005
n = 28
Attitudes towards using Rx for Change in
decision-makingc
3.95 (3.67 to 4.22)
n = 49
0.50 (0.18 to 0.83)
P < 0.005
n = 46
−0.17 (−0.61 to 0.27)
P = 0.445
n = 28
Confidence in skills for using Rx for
Changed
2.38 (2.09 to 2.67)
n = 48
2.08 (1.74 to 2.42)
P < 0.005
n = 47
1.74 (1.37 to 2.11)
P < 0.005
n = 28
Intention to use Rx for Change 3.87 (3.52 to 4.21
n = 48)
0.53 (0.21 to 0.86)
P < 0.005
n = 46
−0.06 (−0.51 to 0.45)
P = 0.908
n = 27
aMean of three questions on perceptions of evidence use as appropriate, important and useful
bMean level of confidence for six skills in using evidence for decision-making
cMean of three questions on perceptions of Rx for Change as appropriate, important and useful
dMean level of confidence for 11 skills in using Rx for Change
Table 2 Self-reported use of Rx for Change in 3 months pre and post the workshop
Answer to the
question ‘how many
times have I used Rx
for Change…
….in the 3 months prior to workshop’
Count (%)
….in the 3 months since the workshop’
Count (%)
n = 49 n = 28
Never or not applicable 38 (78%) 11 (39%)
Once 7 (14%) 8 (29%)
Twice 4 (8%) 5 (18%)
Three times (monthly) 0 (0%) 4 (14%)
Twelve times (weekly) 0 (0%) 0 (0%)
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Confidence in skills for using evidence improved after
the workshop, with the improvement being maintained
3 months later. This is an important result, particularly
for a 1 hour workshop. Similar to confidence in skills for
using evidence, the workshop improved perceptions of
confidence in skills for using Rx for Change, and this
was maintained at 3 months. However, there is a trend
towards declining confidence in skills. This might signal
that additional skill development activities might be re-
quired to support the ongoing use of a database like Rx
for Change.
While consumer-based and provider-based organisa-
tions from different countries were used in the study,
the staff within these organisations undertook similar
duties – outreach to others to improve use of evidence.
The ‘others’ were different but the people we targeted
with the intervention were not that different. If, for ex-
ample, physicians had been the targets of the education,
differences would have been expected. This finding
might improve the generalisability of our findings to a
broad array of policy-based groups. However, caution in
generalising is warranted given our context of only two
countries and both being of high income.
We guided our research using the Knowledge to Ac-
tion framework [22], which gave us a structure that
underpinned the development, pilot and evaluation of
this multi-faceted training program to improve use of Rx
for Change [23]. Another strength of this study is that
the research builds on international collaborations be-
tween Canada and Australia by involving five knowledge
user groups who have expressed the interest in Rx for
Change training, three from Canada and two from
Australia. By involving targeted user audiences we can
better understand the needs of individuals or groups
concerned with the identification and/or implementation
of interventions used to change provider (health practi-
tioner/professional) and consumer (patient) behaviours
as it specifically relates to medicines prescribing or prac-
tice. Limitations of this study include a relatively small
number of sites and participants. In addition, the
3 month follow-up data only included 28 of the 49 par-
ticipants who attended the workshop, resulting in an
even smaller sample at the follow-up, thus increasing
the potential for bias and reducing power to observe ef-
fects. While we did include a 3 month follow-up, the
timing of this follow-up was short, and no further
follow-up took place. The most significant limitations
were the design of the study (a pre–post measurement
with no control group and no ability to measure changes
in responses over time within individuals) and the use of
a survey that was designed specifically for the study.
While we did pilot test the survey for relevancy, clarity
and completeness, we did not undertake additional mea-
sures of reliability and validity. Our conclusions are
therefore tentative and additional experimental research
is needed.
Conclusion
The evaluation component aids understanding and future
activities to optimise use of Rx for Change. Participants of
this tailored training program reported sustained improve-
ments in confidence in skills for using evidence in policy
decision-making. This may have important implications
for uptake of systematic review evidence to promote im-
proved prescribing and medication use.
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